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Abstract
Nesprins-1 and -2 are highly expressed in skeletal and cardiac muscle and together with SUN (Sad1p/UNC84)-domain
containing proteins and lamin A/C form the LInker of Nucleoskeleton-and-Cytoskeleton (LINC) bridging complex at the nu-
clear envelope (NE). Mutations in nesprin-1/2 have previously been found in patients with autosomal dominant Emery–
Dreifuss muscular dystrophy (EDMD) as well as dilated cardiomyopathy (DCM). In this study, three novel rare variants
(R8272Q, S8381C and N8406K) in the C-terminus of the SYNE1 gene (nesprin-1) were identified in seven DCM patients by muta-
tion screening. Expression of these mutants caused nuclear morphology defects and reduced lamin A/C and SUN2 staining at
the NE. GST pull-down indicated that nesprin-1/lamin/SUN interactions were disrupted. Nesprin-1 mutations were also asso-
ciated with augmented activation of the ERK pathway in vitro and in hearts in vivo. During C2C12 muscle cell differentiation,
nesprin-1 levels are increased concomitantly with kinesin light chain (KLC-1/2) and immunoprecipitation and GST pull-down
showed that these proteins interacted via a recently identified LEWD domain in the C-terminus of nesprin-1. Expression of
nesprin-1 mutants in C2C12 cells caused defects in myoblast differentiation and fusion associated with dysregulation of
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myogenic transcription factors and disruption of the nesprin-1 and KLC-1/2 interaction at the outer nuclear membrane.
Expression of nesprin-1a2 WT and mutants in zebrafish embryos caused heart developmental defects that varied in severity.
These findings support a role for nesprin-1 in myogenesis and muscle disease, and uncover a novel mechanism whereby dis-
ruption of the LINC complex may contribute to the pathogenesis of DCM.
Introduction
Dilated cardiomyopathy (DCM) is characterised by dilatation
and impaired contraction of the left ventricle or both ventricles,
and is an important cause of heart failure and sudden cardiac
death, particularly in the young. The genetic causes of DCM are
extremely complicated and over 50 genes have been implicated,
many of them encoding components of the cytoskeleton and
nuclear envelope (NE) (1,2).
Mutations in the LMNA gene, encoding the nuclear inter-
mediate filament proteins lamin A/C, account for 6% of familial
DCM patients in addition to causing a wide spectrum of dis-
eases, named laminopathies. The laminopathies include
Emery-Dreifuss muscular dystrophy (EDMD), which manifests
with skeletal muscle wasting, heart conduction defects (CD) and
DCM (3,4). Mutations in the EMD gene, encoding the inner nu-
clear membrane (INM) protein emerin, a binding partner of
lamin A/C, also cause EDMD with CD (5). How mutations in both
emerin and lamin A/C, which are ubiquitously expressed pro-
teins, can lead to muscle-specific diseases has been a subject of
debate for some time. However, evidence has shown that lamin
A/C and emerin are both associated with the LInker of
Nucleoskeleton and Cytoskeleton (LINC) bridge complex, which
links the nucleus to the actin cytoskeleton. The major compo-
nents of the LINC complex are: nesprins-1 and -2 (NE-spectrin
repeat proteins) and SUN (Sad1p/UNC84)-domain containing
proteins (SUN1/2) (6–8). Nesprin-1 and -2 can bind actin via a
paired N-terminal Calponin Homology (CH) actin binding do-
mains and the nuclear membrane via a C-terminal Klarsicht/
ANC-1/Syne Homology (KASH) domain (9,10). The KASH domain
also binds to SUN1/2 which span the INM and bind to lamin A/C
directly via their N-terminal nucleoplasmic domain, thus
providing a physical connection between the nucleus and the
cytoskeleton (6,11,12). Mutations in nesprin-1 and -2 have been
implicated in EDMD 4 (AD-EDMD 4, OMIM 612998) and 5 (AD-
EDMD5, OMIM 612999), and SUN1 and SUN2 have also been
implicated in EDMD (13–16). Thus, it has been suggested that
disruption of the LINC complex by LMNA and EMD mutations,
as well as SYNE (nesprin) and SUN mutations, may trigger ef-
fects on either chromatin structure causing deregulation of
gene expression, or disruption of structural organisation of the
cell, which is particularly important in muscle as it is subject to
mechanical strain.
Another mechanism that may explain tissue specific disease
is muscle-specific expression of LINC complex components.
Alternative transcription and splicing of SYNE1 and SYNE2, the
genes encoding nesprin-1 and -2, generate multiple isoforms
that vary greatly in size (17). The largest giant nesprin-1 and
-2 isoforms localise at the outer nuclear membrane (ONM) and
connect the nucleus to the actin cytoskeleton. However, smaller
nesprin-1 and -2 isoforms, with a truncated N-terminus but
sharing spectrin repeats (SRs) in common with the C-terminal
regions of the giant proteins, also localise at the INM
where they bind to emerin, lamin A/C and SUN1/2, forming a
complex at the INM (18). These smaller isoforms, in particular,
nesprin-1a2 and -2a1, are highly and specifically expressed in
cardiac and skeletal muscle (7,19). Thus, mutations in SYNE1/2
that disrupt these specific nesprin-1 and -2 isoforms, or muta-
tions in other components of the LINC complex that disrupt
their binding with nesprin-1 and -2, are likely to play a key role
in muscle-specific laminopathies.
In support of this notion, mutations in the C-terminal re-
gions of the nesprin-1 (SYNE1) and -2 (SYNE2) genes have been
identified in patients with muscle specific disorders. This is in
contrast to mutations located towards the N-terminus, which
are associated with ataxia (13,14,20). For example, several mis-
sense mutations in the C-terminus were identified in several
small family pedigrees, as well as in sporadic EDMD patients
with DCM (13). Studies in fibroblasts from these patients
showed abnormal localisation and binding of the LINC complex
proteins lamin, emerin and SUN2, as well as nuclear morph-
ology defects and loss of NE integrity. A missense mutation in
the same C-terminal region of the SYNE1 gene was identified in
a DCM patient, which resulted in increased expression of
nesprin-1 and lamin A/C, also indicating a perturbation of the
LINC complex (14). Furthermore, nesprin-1 KASH domain
knockout (KO) mice developed an EDMD-like phenotype and
DCM (21), displaying muscle degeneration with elongated nuclei
and reduced heterochromatin. Ablation of the C-terminal re-
gions of both nesprin-1 and -2 in cardiomyocytes resulted in
early onset cardiomyopathy (22). These mutant cardiomyocytes
exhibited altered nuclear positioning, shape, and chromatin
positioning, leading to impairment of gene expression in re-
sponse to biomechanical stimuli due to loss of either nesprin -1
or -2 or both (22). Finally, in studies in vitro, overexpressing
dominant-negative versions of nesprin KASH or SUN proteins in
mouse C2C12 myoblasts perturbed the mechanical control of
cell differentiation (23). In these studies, nuclear displacement
and defects in nuclear rotation were also noted, implicating the
LINC complex in myonuclear positioning.
Indeed, recent data have shown that the C-terminal region
of nesprin mediates myonuclear positioning by attaching the
microtubule (MT) network to the NE during embryonic muscle
development and cell migration (24). These interactions occur
via the MT motor proteins, dynein and kinesin, the latter being
a heterotetramer of two kinesin heavy chain (KHC) subunits -
Kif5A, Kif5B, or Kif5C- and two kinesin light chain (KLC)-1/2 sub-
units. Nesprin-2 was shown to interact with KLC-1/2 at the ONM
via a newly identified four-residue tryptophan-acidic (W-acidic)
‘LEWD’ binding motif within an adaptive domain (AD) at its
C-terminus, which is present in all muscle-specific isoforms
(25–27). Disruption of the LINC complex with a dominant-
negative nesprin-2 KASH impaired kinesin-1 association with
the NE and induced nuclear aggregation in myotubes (24). As
both nesprin-1 and -2 are highly conserved in this C-terminal
region, it is likely that nesprin-1 may also mediate the nesprin/
KLC interaction via the ‘LEWD’ binding motif but so far this has
not been tested.
In this study, we screened the SYNE1 and SYNE2 genes in 218
DCM patients. We identified three novel nesprin-1 variants
(R8272Q, S8381C, and N8406K) in seven patients and investi-
gated their roles in NE organisation and myogenesis.
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Results
Identification of three novel nesprin-1 mutants in
DCM patients
Mutation screening of both the SYNE1 and SYNE2 genes was
performed in 218 sporadic cases of DCM and 210 ethnically
matched controls (Supplementary Material, Table S1). 23 exons
for nesprin-1 corresponding to nesprin-1a1 and 1a2 and 16 exons
for nesprin-2 corresponding to isoforms nesprin-2a, 2b and 2e
were screened. This screening strategy was based on high and
specific expression of these isoforms in cardiac and skeletal
muscle as well as mapping of the lamin A/C, emerin, SUN and
KLC binding sites to domains within these isoforms (19,28–30).
Twelve single nucleotide polymorphisms (SNPs)/variants in
SYNE1 were identified, which included intronic sequence vari-
ations (n¼ 2), synonymous (n¼ 5) and non-synonymous, amino
acid exchanges (n¼ 5). Eight of the variants were not present in
420 control alleles of an ethnically matched reference popula-
tion (Supplementary Material, Table S2). No nesprin-2 SNPs/
variants were identified in the region screened. Interestingly,
three of the identified nesprin-1 mutations were unique DNA
variants, which resulted in R8272Q, S8381C, N8406K amino acid
exchanges in the C-terminus of the nesprin-1 giant as well as
within the muscle specific isoform nesprin-1a2, and identified in
seven unrelated DCM patients (Fig. 1A, Supplementary
Material). The amino acids changed by these missense muta-
tions were in regions that were evolutionarily well conserved
and within the mapped emerin and lamin A/C binding domains
(25) and also the proposed KLC-1/2 binding domain in nesprin-1
(24,27) (Fig. 1B). The rarity of these variants and their conserva-
tion and positioning suggest they may be causative for DCM in
the patients examined. ExAC database search revealed
that population frequencies for the R8272Q allele were
0.0002145 (26/121204). Further in silico functional analyses
showed that all three variants are predicted to cause significant
functional impairment for nesprin-1 (Polyphen-2: possibly dam-
aging, SIFT: damaging and Mutation Taster: disease causing).
Therefore, all three rare variants were included in further cell
biological investigations.
Over-expression of nesprin-1 mutants disrupted nuclear
morphology and reduced lamin A/C and SUN2 staining
at the NE
We generated GFP-tagged wild-type (WT) and mutant R8272Q,
S8381C, N8406K constructs in the context of the muscle specific
isoform nesprin-1a2 (Fig. 2A). When transfected into human
osteosarcoma (U2OS) cells, abnormalities of nuclear morph-
ology, measured by nuclei circularity, were induced by con-
structs harbouring the three novel nesprin-1 mutants when
compared with WT (Fig. 2B and E). Immunofluorescence (IF)
staining showed exogenous expression of the mutants, espe-
cially S8381C, caused weaker staining of lamin A/C at the NE
(Fig. 2C and E and Supplementary Material, Fig. S1A), while all
three mutants caused weaker staining of SUN2 at the NE, when
compared with WT nesprin-1a2 (Fig. 2D and E and
Supplementary Material, Fig. S1B). In addition, emerin was mis-
localised by both the WT and mutants when compared with
GFP alone (Fig. 2E). When the same constructs were transfected
into neonatal rat cardiomyocytes (NRCs), IF staining showed
that both lamin A/C and SUN2 staining was weaker at the NE
with all three mutants compared with WT nesprin-1a2 (Fig. 2F
and G and Supplementary Material, Fig S1C and D), indicating
nesprin-1 mutants differentially affect the localisation of NE
binding partners.
Figure 1. Identification of nesprin-1 variants in DCM patients. Mutation screening in SYNE1 and 2 genes was performed in 218 DCM patients and 210 healthy controls,
and identified seven patients harbouring three novel nesprin-1 mutations (R8272Q, S8381C, N8406K, shown in bold) in the C-terminus of nesprin-1 giant (A), equivalent
to nesprin-1a, within an evolutionally conserved region containing the lamin and emerin binding domains (A, B). Previously identified nesprin-1 mutants in DCM
(R8212H) and EDMD-CD patients (R8095H, V8387L and E8461K) were also shown (13,14). The KLC binding motif (LEWD) is shown in (B) (24,27).
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Figure 2. Overexpression of nesprin-1 mutants caused abnormal nuclear morphology and reduced NE staining of lamin A/C and SUN2. GFP-tagged nesprin-1a2 WT and
mutants are shown schematically (A). The full length of this isoform is 977 amino acids, equivalent to amino acids 7875–8796 in nesprin-1 Giant. U2OS cells were trans-
fected with either GFP-nesprin-1a2 WT or mutants. IF staining showed overexpression of mutants, especially S8381C, led to abnormalities in nuclear morphology (B),
reduced lamin A/C and SUN2 staining at the NE (C, D, arrowed). The mis-shapen nuclei were measured by circularity, and mislocalisation of lamin A/C, SUN2 and
emerin in the transfected cells was quantified by comparing the NE staining in non-transfected cells on the same slide. Graphical representation of the frequency of
misshaped nuclei and defects in lamin A/C, SUN2, and emerin at the NE caused by all three mutants (E). At least 100 transfected nuclei were counted in more than
three individual experiments and the results are presented as mean 6 SEM and also analysed by Student’s t-tests and one-way ANOVA. (*P < 0.05 compared with WT;
#: P < 0.05 compared with GFP only). In addition, IF showed both lamin A/C and SUN2 staining at the NE was reduced in the transfected NRCs using GFP-tagged
nesprin1a2 mutant S8381C compared with GFP-tagged WT nesprin-1a2 (F, G, arrowed).
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Nesprin-1 mutants disrupt the interactions between
nesprin-1, lamin A/C and SUN2 within the NE complex
To investigate whether the mutants affected the binding between
nesprin-1 and its NE binding partners, GST-tagged WT and mutant
nesprin-1a2 constructs lacking the KASH domain (equivalent to
nesprin-1 giant amino acids 7875–8662) were generated (Fig. 3A left
panel). Protein lysates from un-transfected U2OS cells and trans-
fected cells with Myc-SUN2 (full length) were subjected to GST
pull-down using either WT or mutant GST-nesprin-1a2. All three
mutants had significantly reduced binding to lamin A/C and SUN2,
but not emerin (Fig. 3A right panel, and B) when compared with
WT nesprin-1a2. A reverse GST pull-down was also performed.
Protein lysates from U2OS cells transfected with either GFP-
nesprin-1a2 WT or each of three mutants were subjected to pull-
down using either GST-lamin A (amino acids 356–665, containing
nesprin-1/2 binding domain) or GST-emerin (amino acids 1–176,
lacking the TM domain). The results confirmed all three mutants
had significantly reduced binding to lamin A (Fig. 3C), but not
Figure 3. Nesprin-1 mutants affect the interaction between nesprin-1a2 and lamin A/C or SUN2. GST-tagged WT nesprin-1a2 SR1-6 (equivalent to nesprin-1 giant SR
69–74) and mutants are generated and shown schematically (3A left panel, labelled with *), which constructs consisted of 837 amino acids, lacking KASH domain,
equivalent to amino acids 7875–8662 of nespin-1 giant. GST pull-down using either GST-WT or mutant nesprin-1 beads showed all three mutants affected binding be-
tween nesprin-1 and lamin A/C or SUN2, but not emerin (A, B), which was confirmed by reverse GST pull down by transfecting either GFP-nesprin-1a2WT or each mu-
tant and using either GST-lamin A (amino acids 356–665) (C) or GST-emerin (amino acids 1–176) beads (D). The binding for each mutant was quantified by densitometry
with respect to the input material and expressed as a ratio of the value obtained for WT protein. Three independent experiments were performed shown as mean 6
SEM, *P < 0.05 using one-way ANOVA analysis. Coomassie blue staining gel also showed equal amount of GST-nesprin 1a2, lamin or emerin beads used.
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emerin (Fig. 3D). Taken together, these data indicated that these
nesprin-1 mutations in the 1a2 region cause disruption of the
lamin A/C, SUN2 and nesprin-1 complex at the INM.
Nesprin-1 mutants augment activation of extracellular
signal-regulated kinase (ERK) pathway
Previous studies have shown that cells harbouring lamin and
emerin mutations have altered activation of ERK1/2 (31,32).
To investigate whether nesprin-1 defects lead to aberrant ERK1/
2 activation, protein lysates from human dermal fibroblasts
(HDFs) derived from EDMD and DCM patients carrying either
nesprin-1, lamin A/C or emerin mutations (13), and heart tissue
from WT and nesprin-1 KASH KO mice with EDMD-like pheno-
type and DCM (21) were examined. Western blot (WB) showed
significant up-regulation of ERK1/2 activity in patient fibroblasts
(Fig. 4A) and nesprin-1 KASH KO mouse hearts (Fig. 4B). To de-
termine whether the novel nesprin-1 mutants could also induce
activation of ERK1/2 signalling, GFP-nesprin-1a2 WT and mu-
tants, as well as a dominant-negative nesprin-1 KASH (1KASH),
which has previously been shown to displace endogenous
nesprin-1 and cause NE defects (6,33), were transiently trans-
fected into C2C12 and H9C2 myoblasts. Immunoblotting with
antibodies against phosphorylated ERK1/2 (pERK) and total
ERK1/2 (tERK) as well as phosphorylated ELK1 (pELK1), a down-
stream target of ERK1/2, demonstrated that overexpression of
the GFP tagged-nesprin-1 mutants and 1KASH increased the
amount of pERK1/2 and pELK1 compared with GFP alone or WT
nesprin-1a2, in both C2C12 cells (Fig. 4C) and H9C2 cells
(Supplementary Material, Fig. S2).
Figure 4. Nesprin-1 mutants cause aberrant activation of MAPKs. WB showed that aberrant activation of pERK was observed in human dermal fibroblasts from EDMD-
DCM patients carrying nesprin-1 mutation (V8387L), lamin A/C (R249Q and R401C) and emerin (g.329del59) mutations (A), as well as nesprin-1 KASH KO mice heart
collected at 17 and 81 weeks, respectively (B). WB also showed overexpression of all three nesprin-1 mutants and dominant negative-1KASH led to augmented pERK ac-
tivity compared with WT nesprin-1 and GFP alone (C). GFP empty vector was used for negative control and a dominant negative-1KASH construct as a positive control.
Three independent experiments were performed shown as mean 6 SEM, *P < 0.05 using one-way ANOVA analysis.
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Nesprin-1 mutants lead to dysregulation of myogenic
transcription factors
To further investigate if these three novel mutants cause
muscle cell dysfunction, we next used the C2C12 mouse myo-
blast differentiation model. Previous studies showed that muta-
tions in LMNA and overexpression of 1KASH or SUN proteins in
C2C12 cells disrupt myoblast differentiation (23,34,35).
Myogenesis is driven by myogenic transcription factors (MTFs)
such as MyoD and myogenin (36,37). To determine the expres-
sion levels of endogenous nesprin-1a, MyoD and myogenin as
well as the skeletal muscle specific protein myosin heavy chain
(MHC) during the differentiation process, protein lysates were
collected at days 0, 2, 4 and 6 following induction (serum with-
drawal). WB and/or qPCR showed that endogenous expression
levels of nesprin-1a (including both 1a1 and 1a2), MyoD, myoge-
nin and MHC were increased along with myotube formation
(Fig. 5A–C, Supplementary Material, Fig. S3). Nesprin-1a levels
peaked at day 6, whereas MyoD and myogenin levels peaked at
day 2. MHC was detected from day 2 and increased until day 6.
Therefore, day 2 for MyoD and myogenin, and day 6 for MHC
were chosen as the optimised investigation time points for early
and late differentiation in further experiments.
To investigate whether the novel nesprin-1 mutants could
disrupt muscle cell differentiation, we used retroviral transduc-
tion to generate C2C12 cells stably expressing V5-tagged
nesprin-1a2 WT and mutant constructs as well as dominant
negative-1KASH, which were cloned into a MIG (IRES-GFP) retro-
viral vector. GFP protein was expressed independently as a re-
porter for retroviral infection. Fluorescence-activated cell
sorting (FACS) was performed to purify the infected GFP positive
populations and these were used in subsequent muscle cell dif-
ferentiation experiments (Supplementary Material, Fig. S4A, B).
IF staining showed that exogenously expressed V5-tagged WT
nesprin-1a2, mutants and 1KASH were observed at the NE in
myoblasts (Fig. 6A, Supplementary Material, Fig. S5A). Efficient
differentiation of C2C12 cells transduced with eGFP alone (MIG
only) or nesprin-1a2 WT was observed, with many multi-
nucleated myotubes formed within 5–6 days. However, fewer
myotubes were formed in the cells transduced with either
nesprin-1a mutants or 1KASH (Fig. 6B, Supplementary Material,
Fig. S5B). Quantification of the fusion index i.e. the percentage
of nuclei incorporated into MHC positive multinucleated cells
vs. the total number of nuclei, showed a significant reduction in
cells transduced with the mutants, in particular, R8272Q and
N8406K as well as 1KASH when compared to WT (Fig. 6C).
Further analysis of the MHC positive populations revealed that
myotubes expressing nesprin-1 mutants contained fewer nuclei
compared to the controls (Fig. 6D), indicating a defect in myo-
blast fusion. Both qPCR and WB showed that the levels of myo-
genin and MHC were dramatically reduced in cells transduced
with the mutants, particularly R8272Q and 1KASH when
compared with nesprin-1a2 WT at day 2 and 6 respectively
(Fig. 6E–G). qPCR also demonstrated that MyoD was significantly
reduced in the cells transduced with 1KASH at Day 2 (Fig. 6E).
Nesprin-1 mutants cause disruption of nesprin-1 and
KLC interaction
Recent data showed that nesprin-2 interacts with KLC-1/2 via a
conserved ‘LEWD’ motif at the C-terminus of nesprin-2 (27).
This motif is also present in nesprin-1 (Fig. 1B) (25–27), suggest-
ing nesprin-1 may also bind to KLC-1/2 and be involved in con-
necting the nucleus to the microtubule network and therefore
play a role in myonuclear positioning. By treatment of C2C12
Figure 5. Expression level of nesprin-1a increase during C2C12 myoblast differentiation. C2C12 myoblasts in regular medium (RM) were stimulated with a low serum
differentiation medium (DM), leading to myotube formation during the process (A). WB showed endogenous expression levels of nesprin-1, myogenin and myosin/
MHC increased during myotube formation (B, C). Nesprin-1a protein levels (detected by MANNES1E) were highest at day 6, whereas myogenin was highest at day 2,
and MHC was detected from day 2 and increased until day 6.
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cells expressing the plasmid containing V5-tagged nesprin-1a2
WT with digitonin or NP-40, we showed that nesprin-1a2 was
also localised at the ONM in addition to its previously identified
INM localisation where it co-localises and binds to lamin A/C
(Supplementary Material, Fig. S6). Therefore, we set out to in-
vestigate whether nesprin-1 could also bind to KLC-1/2. GFP-1a2
WT or nesprin-1a2-LEAA (mutated WD/AA within the LEWD
motif) were co-expressed with Flag-tagged KLC-2 WT
Figure 6. Nesprin-1 mutants cause defects in myoblast differentiation. IF showed that exogenously expressed V5-tagged WT-1a2 or mutants and dominant genative-
1KASH were localized at the NE. GFP was expressed as a reporter for retroviral infection (A). Upon differentiation, fewer multinucleated myotubes were observed in
cells transduced with mutant R8272Q and dominant negative-1KASH compared with C2C12 cells transduced with eGFP alone (MIG only) or nesprin-1a2 WT (B). The fu-
sion index was reduced in cells transduced with the mutant R8272Q and dominant negative-1KASH compared with 1a2 WT (C), more than 600 nuclei for each clone
were counted by microscopy (63 objective) at day 6, three independent experiments were performed for each clone. Further analysis of the MHC positive multi-
nucleated populations revealed that myotubes expressing nesprin-1 mutants contained fewer nuclei compared to the controls (D). qPCR and WB showed that nesprin-
1 mutant R8272Q and dominant negative-1KASH caused significant reduction of myogenin (E, F) and MHC (E, G) levels at DM day 2 and day 6 respectively, qPCR also
showed that dominant negative-1KASH caused significant reduction of MyoD (E) levels at DM day 2. All were normalized to GFP, three independent experiments were
performed shown as mean6 SEM, *P < 0.05 using Student’s t-tests or two-way ANOVA analysis.
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(a dominant light chain isoform in muscle) or the KLC-2 N287L
mutant, previously shown to disrupt nesprin-2/KLC binding (27)
in U2OS cells. Immunoprecipitation (IP) and WB showed that
nesprin-1a2 could efficiently bind to KLC-2, and this binding was
disrupted by either mutation (LEAA) in the conserved nesprin-1
LEWD motif or the KLC-2 N287L mutant (27) (Fig. 7A). We then
tested the nesprin-1 mutants using this system and found that
the R8272Q mutant had significantly reduced binding to KLC-2
compared with nesprin-1a2 WT, while the S8381C mutant ap-
peared to enhance KLC-2 binding (Fig. 7A).
Next we tested whether these mutants affect nesprin-1/KLC-
1/2 binding during muscle cell differentiation. Firstly, WB
showed that, similar to nesprin-1a, the endogenous expression
level of KLC-1/2 increased during myoblast differentiation
(Figs. 5B and 7B). Using GST-nesprin-1a2 WT (lacking KASH do-
main), nesprin-1a2-LEAA and the three mutants, pull-down fur-
ther confirmed that nesprin-1a2 efficiently binds to KLC-1/2, and
this binding was disrupted by the mutated LEWD motif-LEAA.
In addition, the R8272Q mutant had significantly reduced bind-
ing to KLC-1/2 compared with WT in C2C12 cells. This reduced
interaction was especially evident in myotubes where expres-
sion of these two proteins is highest (Fig. 7C and D). Finally, we
tested whether depletion of KLC-1/2 using multiple siRNA oligos
would affect fusion of myoblasts and differentiation in a similar
manner to that observed in the R8272Q mutant. WB showed the
expression levels of both KLC-1 and -2 were reduced in both
myoblasts and myotubes after KLC-1/2 depletion (Fig. 8A and B,
Supplementary Material, Fig. S7C and D), and IF also showed a
reduced KLC-1/2 staining at the NE, however, nesprin-1 re-
mained at the NE (Supplementary Material, Fig. S7A). Moreover,
MHC levels and the fusion index were significantly reduced in
myotubes upon KLC-2 knockdown (Fig. 8C and D,
Supplementary Material, Fig. S7E and F). Further analysis of
MHC positive multinucleated cells (myotubes) revealed that
KLC-2 depletion resulted in fewer nuclei per myotube (Fig. 8E,
Supplementary Material, Fig. S7G), indicating a defect in myo-
blast fusion. In contrast, KLC-1 depletion led to significantly
more clustered nuclei per myotube when compared with con-
trols (Fig. 8E, Supplementary Material, Fig. S7B), indicating a de-
fect in nuclear positioning in addition to myoblast fusion.
Human nesprin-1a2WT causes heart developmental
and conduction defects in zebrafish embryos while
mutants induce a less severe heart phenotype
To investigate whether the nesprin mutants affect cardiac
structure or function in vivo, we generated a zebrafish model by
expressing nesprin-1a2 WT and mutants (R8272Q, S8381C and
N8406K) in zebrafish embryos via injection of the corresponding
human SYNE1a2 (nesprin-1a2) mRNAs at the one-cell stage. At
48 h post-fertilization (hpf), zebrafish embryos expressing
Figure 6. Continued.
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human nesprin-1a2 WT showed heart defects including dilated
atrial chambers with reduced heart rate (Fig. 9A and B,
Supplementary Material, video). There was also evidence of ab-
normal anterior-posterior axis development and curved tails
(Supplementary Material, video). Furthermore, whole-mount in
situ hybridization (WISH) demonstrated that the expression of
myosin light chain polypeptide 7 (myl7), the ortholog of the
human regulatory myosin light chain (RLC) gene (38,39), was
reduced in 30% of the embryos expressing human nesprin-1a2
WT. The expression pattern of this gene also highlighted the
dilated atrial chambers and heart developmental defects such
as abnormal looping (Fig. 9C and D; Supplementary Material,
Figure 7. Defects in nesprin-1 and KLC-1/2 interaction. Overexpression and IP showed the binding between nesprin-1WT/mutants and KLC WT/mutants in U2OS cells,
HA-KLC2-N287L was co-expressed with GFP-nesprin-1a2 WT as a positive control, GFP empty vector with HA-KLC-2 WT as a negative control (A). WB showed endogen-
ous expression levels of KLC-1/2 increased during myotube formation (B). GST pull-down showed the binding between nesprin-1 and KLC-1/2 using either GST-WT or
mutant nesprin-1 beads in myoblasts (C) and myotubes (D), respectively. The binding for each mutant was quantified by densitometry and expressed as a ratio of the
value obtained for WT protein. Three independent experiments were performed shown as mean6 SEM, *P < 0.05 using Student’s t-tests.
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Fig. S8A and B). In contrast, expression of the human nesprin-
1a2 mutants induced some heart developmental defects, such
as abnormal heart looping and malpositioning of heart cham-
bers (Supplementary Material, Fig. S8A and B), but without heart
enlargement or heart rate defects. There was also evidence of
abnormal anterior-posterior axis development in all the em-
bryos, when compared with uninjected and GFP expressed em-
bryos (Supplementary Material, Fig. S8C and D). Taken together
these zebrafish larvae data suggests that overexpression of
human nesprin-1a2 WT leads to cardiac developmental defects
while nesprin-1a2 mutants induced a less severe heart
phenotype.
Discussion
Mutations in lamin A/C and emerin, which form a complex at
the INM, can cause EDMD with conduction system defects, as
well as DCM. Similarly, missense mutations in the C-terminal
region of the nesprin-1 (SYNE1) and -2 (SYNE2) genes and SUN1/
2 genes were identified in EDMD-DCM patients, leading to
Figure 8. siRNA knockdown of KLC-1/2 cause defects in myoblast fusion and differentiation. WB showed the expression levels of both KLC-1 and -2 were reduced in
myoblasts (A) and myotubes (B) upon KLC-1/2 depletion. The expression level of MHC (C) and the fusion index (D) were significantly reduced in myotubes especially
upon KLC-2 depletion (using KLC-2A oligo), more than 800 nuclei for each clone were counted by microscopy (63 objective) at day 6, three independent experiments
were performed for each clone. Further analysis of MHC positive multinucleated cells revealed that KLC-2 depletion resulted in fewer nuclei per myotube. In contrast,
KLC-1 depletion (using KLC-1A oligo) led to significantly more clustered nuclei per myotube when compared with controls (E). Means and SEM were obtained from
three independent experiments for each clone. *P < 0.05 using Student’s t-tests or two-way ANOVA analysis.
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disrupted nesprin/lamin/emerin/SUN1/2 interactions and nu-
clear morphology defects (40,41). In the current study, three
novel missense mutations (R8272Q, S8381C and N8406K) were
identified in the same C-terminal region of nesprin-1 in DCM
patients, which affected nuclear morphology and impaired pro-
tein–protein interaction with lamin A/C and SUN2. The mutants
also augmented ERK activation in vitro. Importantly, these mu-
tations, especially mutant R8272Q, caused defects in myoblast
differentiation associated with dysregulation of MTFs and dis-
ruption of the nesprin-1/KLC-1/2 interaction at the ONM. These
findings provide new information on how nesprin-1 performs
multi-functional roles in muscle cell development and disease
via its connections at both INM and ONM, and also how these
mutations and disruption of the LINC complex contribute to
muscle dysfunction, and potentially the pathogenesis of DCM.
Nesprin-1 mutations interfere with NE organisation
Mutations in the LMNA gene, encoding A-type lamins, cause a
number of different tissue specific laminopathies, including
DCM (42). The molecular pathogenesis of these diseases is un-
known but in some cases may be related to disruption of the
LINC complex. Mice lacking A-type lamins display phenotypes
that are reminiscent of human muscular dystrophies and cardi-
omyopathies (43,44). Embryonic fibroblasts derived from LMNA
KO mice are characterised with grossly misshapen cell nuclei
and a structurally weakened NE, and mislocalization of
nesprins leading to reduced mechanical stiffness (45).
Mutations in both nesprins and SUN1/2 have also been impli-
cated in EDMD-DCM, whereby mutants cause abnormal local-
isation of the LINC complex proteins including lamin, emerin
and SUN, and disrupted nesprin/lamin/emerin/SUN inter-
actions, leading to defects in nuclear morphology and nuclear-
cytoskeletal coupling (13–16). Furthermore, the disruption of
endogenous LINC complexes by recombinant dominant
negative-KASH constructs of nesprins-1, -2 and -3 also causes a
significant loss of mechanical stiffness (6,33,46). Interestingly,
the three novel missense mutations (R8272Q, S8381C and
N8406K) identified in DCM patients in this study reside within
the unique AD region at the C-terminus of the nesprin-1 and -2
proteins (25,26). This region is evolutionally highly conserved
and overlaps with the lamin and emerin binding regions. It has
relatively little secondary structure and is likely to be flexible
(26), and potentially able to adapt its conformation to stabilise
the associations between nesprin SRs, lamin A/C and emerin at
the INM (for nesprin-1a2) or SUN proteins at the ONM (for
nesprin-1a2 and -1 giant isoforms). The three nesprin-1 muta-
tions (R8272Q, S8381C and N8406K) identified in this study cause
changes in the charge or hydrophilic/hydrophobic properties of
conserved amino acids and likely affect the structure/flexibility
of the AD region of nesprin-1, altering it interactions with lamin
A/C and SUN2. These binding changes were most likely due to
Figure 9. Human nesprin-1a2 WT induces heart development defects in zebrafish. Lateral views of zebrafish live embryos at 48 hpf. The pericardium (A, arrowed) and
heart rate are shown for each corresponding mRNA injected (B), zebrafish embryos with nesprin1a2 WT mRNA showed slow heart rate and dilated atrial chambers.
Whole-mount in situ hybridization (WISH) monitoring expression of the myl7 gene at 48 hpf (C), the numbers (left in brackets) indicate the percentage of embryos dis-
playing the phenotype represented in the picture shown, the numbers (right in brackets) is the total numbers counted of observed embryos. The relative atrium area of
embryos for the corresponding mRNA injection was measured and calculated by the area of myl7 expression using ImageJ (D), which was normalised to the atrium
area of the embryos injected with GFP mRNA. Embryos are in ventral views with the anterior at the top. About 4–7 embryos for each injection were measured. Means
and SEM were obtained from three independent experiments for each treatment. P < 0.001 using Student’s t-tests. a: atrium, v: ventricle.
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disruption of the functions of all the endogenous nesprin-1 iso-
forms containing the KASH domain in the transfected cells (19).
Interestingly, the R8272Q mutant was able to bind lamin A at
comparable levels to the WT nesprin-1, in contrast to weak
binding to lamin C. Our current understanding of the inter-
actions between nesprins and lamin A and lamin C remains in-
complete, so this apparent binding difference requires further
investigation. We did not observe a defect in binding between
nesprin-1 mutants and emerin, which is consistent with the no-
tion that mutations in emerin are primarily associated with
EDMD rather than DCM (28,47). The data above support possible
involvement of LINC complex disruption in the pathogenesis of
DCM. Future studies on structure/flexibility of the SRs that are
predominantly present in the muscle-specific nesprin isoforms
will be required to confirm this hypothesis.
Several studies on LMNA KO and H222P knock-in mice have
indicated activation of MAPKs in the development of DCM.
Inhibitors of MAPKs could partially rescue the DCM phenotype,
implicating ERK in the pathogenesis of lamin A/C cardiomyop-
athy (48,49). Our data showed that enhanced ERK activity is also
observed in heart tissue from the nesprin-1 KASH KO mice,
fibroblasts derived from EDMD-DCM patients and nesprin-1 mu-
tant transfected cells, suggesting that nesprin and lamin A/C
function through a similar pathway and trigger up-regulation of
ERK. Future work will examine how NE proteins regulate ERK
activity potentially via influencing interactions between A-type
lamins, NE proteins and components of MAPK cascades, as well
as nuclear translocation of activated MAPKs (50,51).
Nesprin-1 mutations and dysregulation of MTFs in
myoblast differentiation
Nesprin-1a2 is highly expressed in both skeletal and cardiac
muscles as previously shown (7,52,53). Although there were no
obvious muscle phenotypes recorded, it is plausible that in the
patients presenting with the SYNE1 mutations the skeletal
muscle dysfunction was too subtle or underestimated at clinical
examination. Alternatively, in addition to these SYNE1 muta-
tions, another cardiac disease gene is mutated thus enhancing
the phenotype. Therefore, due to restricted accessibility to pa-
tient samples, we focused on investigating if these three novel
mutants cause muscle dysfunctions by using the C2C12 mouse
myoblast differentiation model.
Myogenesis involves a series of sequential steps. Myoblasts
originating from the mesoderm are converted to skeletal muscle
lineage myoblasts after MyoD expression, enter the cell cycle
and proliferate, then withdraw from the cell cycle and initiate
differentiation with expression of MTFs such as myogenin (54).
Next cell fusion occurs to form multinucleated myotubes and
expression of the muscle specific protein MHC. Increasing evi-
dence indicates that multiple cell signalling pathways play crit-
ical roles in myoblast fusion, including those involved in
cytoskeleton organization, cell adhesion and migration (55) as
well as extracellular signalling molecules and components of
extracellular matrix (54,56). Recent literature shows that LINC
complex components, including nesprins and SUN1/2, mechan-
ically couple the nucleus to the extracellular matrix and play an
important role in differentiating muscle. In addition, these pro-
teins have been implicated in regulating chromatin structure
and gene expression. For example, C2C12 cells expressing a
LMNA R453W mutant have reduced capacity to differentiate, yet
retain an unaltered morphology (57), suggesting that subtle ab-
normal changes in lamina structure or composition may impair
the anchoring of chromatin to the NE, affecting gene regulation
and perturbing myogenesis.
Using retroviral transduction in mouse C2C12 myoblasts in
the current study, our data showed myoblasts expressing mu-
tant nesprin-1a2 R8272Q or dominant negative-1KASH had a sig-
nificantly lower capacity to differentiate and form
multinucleated cells than those expressing 1a2 WT, although
exogenously expressed 1a2 WT and mutants were observed to
be properly localised at the NE. Importantly, the inhibition of
multinucleation by dominant negative-1KASH and 1a2 mutants,
especially R8272Q, is potentially linked to the inhibition of myo-
genin and MHC expression in the transduced C2C12 cells. Our
data also showed that nesprin-1a2 was expressed in the initial
stage crucial for converting C2C12 myoblasts into myotubes and
promoted myoblast differentiation during the process of myo-
tube formation, whereas the mutants reduced or abolished the
effects, suggesting that expression of nesprin-1a2 mutants does
not alter the proliferation of myoblasts, but rather impairs their
capacity to express muscle-specific genes (myogenin and MHC).
This results in an inability to fuse, especially observed in the
R8272Q mutant, which also explains why nesprin-1 mutants af-
fect the expression levels of myogenin more severely than
MyoD, because MyoD is already expressed prior to initiation of
differentiation at a stage when the expression level of nesprin-1
is still low. Therefore, we propose the following mechanisms
whereby nesprin mutants may affect muscle differentiation:
regulation of myogenin and expression of MHC are influenced
by the LINC complex; nesprin mutants may fail to build a func-
tional scaffold and/or to maintain chromatin compartmental-
isation with lamin A/C, leading to an alteration in the amount
of heterochromatin formed and/or its localisation. Potentially
this causes defects in initiation of the terminal differentiation
process resulting in decreased or delayed expression of myoge-
nin and MHC, thus causing a delayed differentiation. This effect
may be similar to that observed in C2C12 cells expressing an
LMNA R453W mutant (57) that showed a reduced capacity to dif-
ferentiate. However, further experimentation on how the
nesprin-1 mutants affect regulation of MTFs is required to eluci-
date the precise function of nesprin in muscle cell
differentiation.
Nesprin-1 mutations disrupt nesprin-1/KLC interaction
and myoblast fusion
Proper nuclear positioning and movement is critical in muscle
cell differentiation and development. In the nucleus, changes in
gene activity that occur during terminal cell differentiation are
correlated with gene migration and relocation (58,59). Nuclear
movement and positioning are driven by cytoskeletal networks
of MTs, actin and/or intermediate filaments and involve a con-
nection between the cytoskeleton and the NE, mediated by the
LINC complex (60,61). KO mouse studies have shown that
nesprin-1 and SUN1/SUN2 play critical roles in anchoring nuclei
in skeletal muscle (62,63). Similarly, mutations identified in
SUN1 and SUN2 genes associated with EDMD like phenotypes
cause defective nuclear positioning when expressed in mouse
fibroblasts (15,16). The MT-based kinesin motor, kinesin-1, con-
sisting of two KHCs and two KLCs, is localised at the NE. Binding
of the dominant light chain isoform in muscle, KLC-2, to
nesprin-2 has been shown to be responsible for nuclear rota-
tions and movement along MTs (27). There is evidence that nu-
clear position can influence gene expression. For example,
nuclei at the neuromuscular junction (NMJ) have a unique
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transcriptional profile relative to the non-synaptic nuclei (59).
Nesprin-1 (SYNE1) levels are much higher in synaptic nuclei
than extrasynaptic nuclei, and also higher in myotubes than
myoblasts in culture and central nuclei during regeneration
(52,64). In addition, maintaining proper nuclear positioning is
thought to ensure sufficient transcriptional capacity and min-
imise transport distances between the nuclei and the cytoplasm
in highly organised long muscle cells (60,65). Our data con-
firmed that nesprin-1 binds to KLC-1/2, and nesprin-1 mutants,
particularly R8272Q, disrupted this interaction. Furthermore,
depletion of KLC-1 resulted in nuclear clustering, whereas de-
pletion of KLC-2, a dominant muscle isoform, caused reduction
of MHC levels and the fusion index in myotubes, that was con-
sistent with those observed in the R8272Q mutant. This disrup-
tion of nesprin-1/KLC interaction in C2C12 myoblasts may
result in defects in nuclear movement along MTs, leading to ab-
normal nuclear positioning. Further investigations are required
to elucidate the precise roles of nesprin-1 and KLC-1 and -2 in
myonuclear positioning in muscle cell differentiation.
Expression of nesprin-1a2 mutants induce less severe
heart defects during zebrafish heart development
compared to 1a2 WT
To investigate whether the nesprin mutants affect cardiac
structure or function in vivo, we generated a zebrafish model by
expressing human nesprin-1a2 WT and mutants (R8272Q,
S8381C and N8406K) in zebrafish embryos via injection of the
corresponding human SYNE1a2 (nesprin-1a2) mRNAs. Our data
showed that human nesprin-1a2 WT causes heart developmen-
tal and conduction defects in zebrafish embryos, and all three
1a2 mutants caused less severe heart developmental defects.
Although these results are unexpected, there are some potential
explanations. Human nesprin-1a2 is not expressed in the heart
and muscle until the initial stages of muscle cell differentiation
(7,52,53). Therefore, injection of human nesprin-1a2 mRNA into
zebrafish larvae at the one cell stage, when the expression level
of endogenous nesprin-1 was minimal, caused ectopic expres-
sion effects on heart development. The effect of the mutants
was less severe potentially because their binding interactions
are compromised leading to less disruption. Future studies uti-
lising the zebrafish model with either cardiac (tissue specific)/
heat shock protein (timing dependent) promotors or CRISPR/
Cas9-mediated knock-in is required to clarify underlying dis-
ease mechanism.
In summary, our data support the hypothesis that nesprin-1
plays multi-functional roles at both INM and ONM during
muscle cell development and disease (Fig. 10). Although the role
of nesprin-1 dysfunction in DCM requires further experimenta-
tion, we show that novel nesprin-1 mutants affect diverse func-
tions, including gene expression and myoblast fusion and
differentiation. Further investigation is now required to eluci-
date the complex mechanisms behind this dysregulation espe-
cially in the cardiac system.
Materials and Methods
Research subjects
The study cohort consisted of 218 unrelated individuals with
DCM and 210 healthy controls, collected from the West China
Hospital, Sichuan University, China. All blood materials of the
patients and controls included in this study were taken with in-
formed consent for DNA analysis and approval of the local eth-
ics board. The clinical characteristic of the patients and controls
were summarized in Supplementary Material, Table S1 and
Supplementary material. Most of DCM patients were men and
had significantly larger left ventricular (LV) chamber and lower
left ventricular ejection fraction (LVEF) when compared with
the ethnic and age-control samples.
Figure 10. Working model for the role nesprin-1. The schematic figure shows nesprin-1 plays multiple-functions at both INM and ONM, and how mutants can disrupt
the NE-LINC complex, contributing to the pathogenesis of muscle disease. *Indicates where the mutants are.
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Mutation analysis
Primer pairs were designed across the intron/exon boundaries
and untranslated regions of nesprin-1a1 and 1a2, nesprin-2a1,
2a2, 2b, 2e1 and 2e2, i.e. the smaller INM localised isoforms of
nesprin-1 and nesprin-2 shown to bind emerin and lamin and
be either highly or specifically expressed in muscle tissue. 180
oligonucleotide primers from intronic sequences for 88 exons
were designed using the program Primer3Input (primer3_www.
cgi v 0.2) and used previously (13). Mutation screening was per-
formed using the PCR-based mutation detection technique
DHPLC (WAVE 4500B system, Transgenomic). Appropriate
DHPLC conditions for running temperatures and buffer gradi-
ents were established for each individual exon.
Plasmid constructs/retroviral constructs/site-directed
mutagenesis
Human cDNA of nesprin-1a2 WT constructs (amino acids 1–977,
equivalent to nesprin-1 giant 7875–8796) were amplified using a
high-fidelity GC-rich PCR kit (Roche) and inserted respectively
in-frame into the EcoRI site of the pEGFP-C1 vector (Clontech)
for overexpression of GFP-nesprin, and the NotI and EcoRI sites
of pcDNA3.1(-) vector (Invitrogen) for in vitro synthesis of Flag-
tagged nesprin mRNA and microinjection. GST nesprin-1a2 SR1-
6 construct (amino acids 1–837, lacking KASH domain, equiva-
lent to nesprin-1 giant 7875–8662, SR 69–74) and V5-tagged
nesprin-1a2 construct (amino acids 1–977, equivalent to
nesprin-1 giant 7875–8796) were amplified from the established
pEGFP-C1-nesprin-1a2 WT construct and inserted into EcoRI
and SalI sites of the pGEX-4T-1 vector (Pharmacia) and EcoRI
and NotI sites of the MIGplus retroviral vector respectively. The
MIGplus vector was a kind gift from Prof. Peter Zammit (66),
which was modified from the retroviral (RV) backbone pMSCV-
puro (Clontech, Mountain View, CA), in which the puromycin
selection gene was replaced with eGFP to create pMSCV–IRES–
eGFP, served as the RV control vector and eGFP as a reporter for
retroviral infection. Retroviruses were then packaged into 293T
cells using standard methods as described previously (66). All
the constructs of nesprin-1 mutant constructs (R8272Q,
S83831C, N8406K) were generated using QuickChangeTM XL
site-directed mutagenesis kit (Stratagene). Primers for the con-
structs above are listed in Supplementary Material, Tables
S3–S5. Myc-SUN2 has been reported previously (67). CB6-HA-
KCL2 WT and mutant N287L were kind gifts from Dr Mark
Dodding (King’s College London, UK). GST-lamin A (amino acids
356–665) and GST-emerin (amino acids 1–176) were kind gifts
from Dr Juliet Ellis (King’s College London, UK).
Cell nuclei circularity quantification
‘Analyse particles’ function in ImageJ was used to measure cir-
cularity of cell nuclei, with circularity values given between 0
and 1 (values closer to 1 being more circular in shape) (68).
Antibodies and immunofluorescence
Primary antibodies were sourced as follows: lamin A/C (N-18,
sc-6215, Santa Cruz), SUN2 [kind gifts from Dr Didier Hodzic,
University of Washington, US and (67)], emerin (NCL-EMERIN,
Novacastra), GFP (ab290, ab13970, Abcam), GAPDH (sc-25778,
Santa Cruz), b-actin (A5316, Sigma), a-tubulin (ab52866, Abcam),
phospho-p44/42 MAPK (pERK1/2) (4370, Cell Signalling
Technology), p44/42 MAPK (tERK1/2) (9102, Cell Signalling
Technology), V5 (R96025, Invitrogen), nesprin-1 (MANNES1A
and MANNES1E (52), generated against the C-terminus of the
nesprin-1 giant), myogenin (sc-576, Santa Cruz), myosin (clone
A4.1025, against all isoforms expressed by MYH1, Alexis
Corporation), HA (ab1424, Abcam), KLC-1/2 (63–90, a kind gift
from Prof Scott Brady, University of Illinois at Chicago, USA).
Alexa fluorophore (488/546/647)-conjugated secondary antibod-
ies were from Invitrogen. HRP-conjugated secondary antibodies
were from Amersham. IF staining was performed as described
previously (13). In particular, to further define the subcellular lo-
calisation for GFP-tagged nesprin-1a2, the transfected cells were
fixed by 4% paraformaldehyde/PBS, then permeabilized using
either 0.001% digitonin/PBS or 0.5% NP40/PBS.
Cell culture, transfection and RNAi
HDFs, U2OS, C2C12 myoblasts were cultured at 37 C/5% CO2 in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal calf serum (FCS) and 1% Pen-Strep-Glutamine
(PSG). For myoblast differentiation, C2C12 were cultured in low-
mitogen medium (DMEM supplemented with 1% PSG and 2%
horse serum) as described previously (7). For transient transfec-
tion, cells were plated onto glass coverslips or T25 flask at ap-
proximately 1.2 105 cells/ml and transfected using FuGENE
HDTM (Promega) according to the manufacturer’s instructions
and fixed for IF staining or harvested for Western blotting 24 h
after transfection as described previously (7,13). siRNA transfec-
tions were also performed by using HiPerFect (Qiagen) according
to the manufacturer’s instructions. KLC-1/2 siRNA oligomers
targeting to the mouse KLC-1/2 were previously described (27)
and obtained from Dharmacon, named as KLC-1A and KLC-2A.
Additional four KLC-1/2 siRNA oligos obtained from Qiagen (Cat.
No: SI01085154, SI01085168, SI01083327 and SI01083341) were
renamed as KLC-1B and -1C, KLC-2B and -2C respectively.
Allstars negative control siRNA was also supplied from Qiagen.
Neonatal rat cardiomyocytes (NRCs) isolation, culture
and transfection
Primary cultures of NRCs were isolated from 1- or 2-day-old
neonatal Sprague–Dawley rats. Hearts were collected and atria
were removed. Hearts were then washed, excised, minced and
enzymatically digested at 37 C with ADS buffer [116 mmol/L
NaCl, 20 mmol/L HEPES, 0.8 mmol/L NaH2PO4, 5.6 mmol/L glu-
cose, 5.4 mmol/L KCl, 0.8 mmol/L MgSO4] containing collagenase
(57.5 U/mL) and pancreatin (1.5 mg/mL). The suspension was
pre-plated to remove contaminating cells, before being cultured
on gelatin (Sigma) pre-coated 35 mm petri dishes with a density
of 2  105 cells/ml. Cells were allowed to adhere for 24 h, and
then transfected using Escort III (Sigma) following the manufac-
turer’s instruction as described previously (69).
Retroviral infection and myoblast differentiation
Retroviral constructs, together with an ectopic packaging plas-
mid, were transiently co-transfected into 293T cells to produce
non-replicating retrovirus and the supernatant harvested 48, 60
and 72 h later. Retroviral infection was performed as described
previously (66). Briefly, C2C12 cells were plated in T25 flasks.
After 24 h, the medium was replaced with a 1:5 dilutions of 293T
retroviral supernatant supplemented with 4 mg/ml polybrene
and incubated at 37 C for 4–6 h, and then changed into fresh
medium. FACS was performed to purify the infected GFP
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positive cells in 48 h and these were used to in subsequent myo-
blast differentiation experiments. To induce differentiation, the
medium was replaced with the differentiation medium (DM)
containing 2% horse serum and 1% PSG, and cell lysates were
collected for further investigation at day 0, 2, 4 and 6.
Co-immunoprecipitation assays
U2OS cells were transfected using GFP-nesprin-1a2 WT/mutants
with HA-KLC-1/2 WT/mutant as well as Myc-SUN2 respectively,
harvested about 24 h later and kept in IP buffer [10 mM Tris (PH
7.4), 50 mM NaCl, 5 mM EDTA, 1% Triton X-100] with protease in-
hibitor cocktail (Sigma) on ice for 30 min, followed by 10 s sonic-
ation and centrifugation. About 500 mg of protein was pre-
cleaned with Protein A/G sepharose beads (Sigma) for 1 h at 4 C.
Beads were removed by centrifugation and 2.5 mg primary anti-
body was added to lysates and left rotating at 4 C for 16 h.
Beads were then added to reactions and incubated for 2 h rotat-
ing at 4 C. Samples were centrifuged and supernatant dis-
carded. Pellets were washed and re-suspended in sample
buffer, heated at 95 C for 10 min and analysed by WB as
described previously (13).
GST pull-down assays
GST fusion proteins and GST alone were induced from 100 ml of
bacterial culture for 4 h by addition of 0.2 mM isopropyl-1-thio-
b-D-galactopyranoside. Purification of the proteins was per-
formed according to the Amersham Biosciences protocol using
glutathione-Sepharose 4B beads (Amersham Biosciences). Pull-
down assays were performed as described previously (70).
Briefly, 200 lg extracts from U2OS or C2C12 myoblasts/myotubes
were incubated with 50 ll beads with constant rotation for 16 h
at 4 C. Bound proteins were washed and eluted into sample
buffer, followed by WB. In particular, to investigate the inter-
action between nesprin-1 and its NE binding partners, protein
lysates from Myc-SUN2 transfected (for SUN binding) and
untransfected U2OS cells (for lamin A/C and emerin binding),
C2C12 myoblast and myotubes (for KLC-1/2 interaction) were
harvested and subjected to pull down using either GST-WT or
mutant nesprin-1a2 SR1-6 beads. To further confirm the bind-
ings, U2OS cells were transfected with either GFP-nesprin-
1a2WT or mutants, protein lysates were harvested and
subjected to pull-down using either GST-lamin A (amino acids
356–665) or GST-emerin (amino acids 1–176).
Quantitative RT-PCR (QPCR)
C2C12 Cells were cultured in T25 flasks in proliferation or differ-
entiation medium. Total RNA was extracted using RNA-STAT 60
(Amsbio) according to manufacturer’s protocol. Reverse tran-
scription synthesis of cDNA and qPCR was performed as
described previously (13). Relative expression of each myogenic
transcriptional factor between proliferating and differentiated
cells was measured in three replicates in at least three inde-
pendent experiments. Primers for myogenin, MHC, MyoD, V5
and GFP have been previously described and listed in
Supplementary Material, Table S6.
Zebrafish embryos
WT embryos from AB strain were used. Embryos were obtained
by natural matings and cultured in embryo medium (71).
Staging of the embryos was carried out as described by Kimmel
et al. (72). Ethical approval was obtained from the Animal Care
and Use Committee of Sichuan University.
In vitro synthesis of mRNA and microinjection
Capped GFP and nesprin mRNAs were synthesized using
mMESSAGE mMACHINEVR Kit (Ambion); Synthetic capped
mRNAs were injected into single-cell embryos. Injection dose
(60 mg) was an optimised amount received by a single embryo.
Zebrafish whole-mount in situ hybridization
Whole-mount in situ hybridization was carried out as previously
described (73,74). After linearization by appropriate restriction
enzymes, antisense RNAs for in situ hybridization were synthe-
sized using DIG RNA Labelling Kit (SP6/T7) (Roche) and purified
by MEGAclear (Ambion). Signal area of whole-mount in situ hy-
bridization was measured by software ImageJ.
Statistical analysis
Cell counts for statistical analysis were performed on n ¼ 100–
200 cells/n¼ 10 confocal microscope fields (63 magnification)
for each control and experimental group, and results were veri-
fied in at least three independent experiments. The data were
analysed using GraphPad Prism software by the Student’s t-
tests, One way or Two-way analysis of variance (ANOVA) with
Dunnett’s multiple comparison test for two independent groups
or multiple comparisons, respectively. The values are expressed
as mean6 standard error of mean (SEM). The P-values< 0.05
were considered statistically significant.
Supplementary Material
Supplementary Material is available at HMG online.
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